Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 17,703 | 15,848 | 10,470 | 9,450 | 5,091 |
| Operating Income | -17,703 | -15,848 | -10,470 | -9,450 | -5,091 |
| Other Income | 1,387 | 1,481 | 1,160 | 671 | 909 |
| Pre-tax Income | -16,316 | -14,367 | -9,310 | -8,779 | -4,182 |
| Net Income Continuous | -16,316 | -14,367 | -9,310 | -8,779 | -4,182 |
| Net Income | $-16,316 | $-14,367 | $-9,310 | $-8,779 | $-4,182 |
| EPS Basic Total Ops | -0.75 | -0.66 | -0.71 | N/A | -1.05 |
| EPS Basic Continuous Ops | -0.75 | -0.66 | -0.71 | N/A | -1.05 |
| EPS Diluted Total Ops | -0.75 | -0.66 | -0.71 | N/A | -1.05 |
| EPS Diluted Continuous Ops | -0.75 | -0.66 | -0.71 | N/A | -1.05 |
| EPS Diluted Before Non-Recurring Items | -0.75 | -0.66 | -0.71 | N/A | N/A |
| EBITDA(a) | $-18,065 | $-16,457 | $-10,546 | $-9,538 | $-5,091 |